Information Provided By: 
Fly News Breaks for January 23, 2020
AMGN
Jan 23, 2020 | 06:39 EDT
Citi analyst Mohit Bansal raised his price target for Amgen to $275 from $245 saying he thinks the "story has more room to run." Amgen appears to be trading in-line with big pharma despite having higher earnings growth, Bansal tells investors in a research note. The analyst also sees pipeline catalysts as the "key triggers for multiple expansions" and he notes that Amgen "has plenty" with four pivotal readouts this year. He keeps a Buy rating on the shares.
News For AMGN From the Last 2 Days
There are no results for your query AMGN
